Across Global Alliance Selects Wemedoo's oomnia® as Central Clinical Trial Infrastructure
Across Global Alliance has partnered with Wemedoo AG to implement oomnia as its centralized clinical trial infrastructure, enhancing efficiency, compliance, and collaboration across its alliance members operating in over 90 countries.
After an extensive evaluation of available solutions, oomnia emerged as the only system capable of meeting the alliance's complex operational needs. By integrating essential clinical trial functions, including EDC, CTMS, RTSM, and eTMF into a single, unified platform, oomnia eliminates inefficiencies caused by fragmented systems and disjointed data workflows.
"Running global clinical trials requires a system that facilitates seamless collaboration, eliminates unnecessary delays, and ensures data consistency across all sites. With oomnia, we have found a platform that meets these demands while maintaining compliance and operational flexibility," said
With oomnia as its digital backbone, Across Global Alliance ensures that all its clients and members benefit from a system that optimizes clinical trial execution, provides real-time data quality reviews, and is easy to navigate.
"This partnership with Across Global Alliance is another step toward transforming how clinical trials are managed. By providing a truly integrated and adaptive system, we enable alliance members to focus on scientific progress rather than administrative complexity," said
Contact: Steven Bukvic
Email: [email protected]
For more information visit Wemedoo & Across Global Alliance
About Across Global Alliance
Across Global Alliance is a
About Wemedoo
Wemedoo AG, a Swiss-based company specializes in healthcare data-driven solutions. By combining advanced technologies with deep clinical expertise, Wemedoo empowers research teams, CROs, and sponsors to conduct clinical trials more efficiently, reduce costs, and accelerate medical innovation.
Logo - https://mma.prnewswire.com/media/2629680/Wemedoo_AG_Logo.jpg
View original content to download multimedia:https://www.prnewswire.com/news-releases/across-global-alliance-selects-wemedoos-oomnia-as-central-clinical-trial-infrastructure-302387807.html
SOURCE Wemedoo AG
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CIEE BridgeUSA Celebration Tour Visits Ocean City, Maryland, to Highlight How BridgeUSA Makes America Safer, Stronger, and More Prosperous
- UGREEN Unveils New MagFlow Lineup, Featuring the World's First Liquid-Cooled Qi2 25W Magnetic Power Bank
- GLP-1 Use Among Young Children With Obesity in US Remains Rare but Is Rising Rapidly
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share